Word

S SENSILE MEDICAL

Status

Registered

Status Code

700

Status Date

Tuesday, August 6, 2024

Serial Number

98113258

Registration Number

7466487

Registration Date

Tuesday, August 6, 2024

Mark Type

3

Filing Date

Wednesday, August 2, 2023

Published for Opposition

Tuesday, May 21, 2024

Trademark Owner History

Sensile Medical AG - Original Registrant

Classifications

44 medical services, in particular in the field of care for diabetics; medical testing services and medical analysis for the diagnosis and treatment of persons; diagnosis of diseases, in particular diabetic diseases; pharmaceutical advice, medical and pharmaceutical consultancy, particularly in the field of diabetes; medical equipment rental; information, advice and medical consultancy, particularly relating to the treatment and care of diabetes, provision of educational information on diabetes via a website; provision of information on the use of medical testing apparatus and consultancy in the field of medical diagnostics via a website

10 medical apparatus and instruments, namely, electromagnetic drug delivery apparatus for medical use, infusion and injection devices for administering drugs, drug delivery ports and pumps for delivering drugs beneath the skin; apparatus for analyzing blood and blood plasma; apparatus for extracting and analyzing blood, namely, hematology analyzers, hematology rheometers, blood gas analyzers, biochemistry analyzers, hemagglutinators, and chemiluminescence immunoassay analyzers for medical diagnostic uses; apparatus for diagnoses and for analyses for medical use, in particular glucose meters, devices for measuring blood sugar, namely, blood glucose meters, and glycerin concentration meters;medical apparatus for introducing pharmaceutical preparations into the human body, in particular apparatus for introducing insulin and glucagon, namely, jet injectors for medical use; portable pumps and patch pumps for medical use, in particular mobile and portable pumps and patch pumps for the transcutaneous and subcutaneous administering of drugs and active ingredients for diabetes management, for the treatment of degenerative disorders of the central nervous system, and for therapies that periodically require the delivery of a certain total quantity of a formulated drug; insulin and glucagon pumps; belts for medical use; injectors for medical use, namely, infusion pumps, syringes for injections, and medical fluid injectors for transcutaneous and subcutaneous delivery of medication including insulin and glucagon; injection instruments with needles for injecting insulin and glucagon; brush pens and dispensation devices in the form of injection instruments with needles for accurate, precise dosing and application of medical or cosmetic creams and preparations; medical test kits for diabetes control for clinical or household use

42 scientific and technological services, namely, scientific research and design in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; scientific and technological services, namely, scientific research and design in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; technological advice in the field of the technology of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; scientific laboratory services; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; industrial analysis of medical equipment for use in the management and treatment of diabetes, growth hormone deficiency, pain therapy, and chemotherapy related medical equipment, and scientific research services; industrial analysis and research services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; bacteriological research services; biological research services; chemical research services; chemical analysis; design and development of products in the field of fluids, mechanics, electronics and software; technical project studies in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; research and development of new products for others; technical research services in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring technology; carrying out scientific feasibility studies; testing of materials; calibration services; quality control for others; design and development of software; installation, maintenance and updating and rental of software; software consultancy, namely, consultation about the maintenance and updating of computer software

The mark consists of the word "SENSILE" in gray above the word "MEDICAL" in blue. To the left of these words is a stylized white letter "S" inside a blue square with two rounded corners.
The color(s) blue, gray, and white is/are claimed as a feature of the mark.
"MEDICAL"

Trademark Events

Aug 5, 2023

New Application Entered

Aug 31, 2023

New Application Office Supplied Data Entered

Sep 1, 2023

Notice Of Design Search Code E-Mailed

Apr 10, 2024

Correspondence Received In Law Office

Feb 8, 2024

Assigned To Examiner

Feb 22, 2024

Non-Final Action Written

Feb 22, 2024

Non-Final Action E-Mailed

Feb 22, 2024

Notification Of Non-Final Action E-Mailed

Apr 10, 2024

Teas/Email Correspondence Entered

Apr 10, 2024

Teas Response To Office Action Received

Apr 17, 2024

Examiners Amendment -Written

Apr 17, 2024

Examiners Amendment -Written

Apr 17, 2024

Examiners Amendment E-Mailed

Apr 17, 2024

Notification Of Examiners Amendment E-Mailed

Apr 17, 2024

Examiner's Amendment Entered

Apr 17, 2024

Examiners Amendment E-Mailed

Apr 17, 2024

Notification Of Examiners Amendment E-Mailed

Apr 17, 2024

Examiner's Amendment Entered

May 1, 2024

Notification Of Notice Of Publication E-Mailed

Apr 17, 2024

Approved For Pub - Principal Register

May 21, 2024

Published For Opposition

May 21, 2024

Official Gazette Publication Confirmation E-Mailed

Aug 6, 2024

Registered-Principal Register

Aug 6, 2024

Notice Of Registration Confirmation Emailed